Clinical Success and Quality of Life With Brimonidine 0.2% or Timolol 0.5% Used Twice Daily in Glaucoma or Ocular Hypertension: A Randomized Clinical Trial
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Ophthalmology
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Health-related quality of life of North American patients with eye diseases: a systematic review;JFO Open Ophthalmology;2023-12
2. Surgical Outcomes of a Small Incision Limbus-Based Revision for Failed Trabeculectomies;Open Journal of Ophthalmology;2022
3. A review of neuropsychiatric adverse events from topical ophthalmic brimonidine;Human & Experimental Toxicology;2020-04-29
4. Effect of benzalkonium chloride–free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study;BMC Ophthalmology;2015-11-12
5. Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy;Journal of Ocular Pharmacology and Therapeutics;2015-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3